Innovation SuperNetwork

At Holly Health, we are transforming the way individuals approach mental and physical well-being. Founded in 2020, we’ve developed an AI-powered digital health coach that empowers users to turn their health intentions into clear, actionable steps. Our personalized, compassionate service is designed to fit seamlessly into everyday life, supporting long-term, sustainable health changes. Using proprietary AI systems, Holly Health mimics the guidance of a human health coach, offering support in areas such as weight management, stress reduction, wellness, and sleep. We are proud to be ranked among the top 3 health apps by ORCHA, the world’s leading health app evaluation body, with a score of 89%. Since our international launch in 2021, Holly Health has been on a mission to improve the lives of 5 million people by 2025. We are rolling out partnerships with over 100 primary care practices in the UK, helping healthcare professionals support patients with preventative health measures and ongoing well-being. At Holly Health, we believe that health is not a destination but a journey. By offering tailored, science-backed coaching, we make it easier for people to prioritize their well-being every day. Join us as we revolutionize digital health coaching for the modern world.

Holly Health is a digital health coaching application that assists individuals in transforming their health intentions into actionable daily habits for improved mental and physical wellbeing. Utilizing proprietary AI systems, the service mimics the support of a human health coach, offering personalized guidance to users. The application features tools such as habit reminders, tailored health content, and progress tracking, all aimed at helping users establish and maintain healthier routines. Recognized as one of the top health apps for weight management, stress reduction, wellness, and sleep, Holly Health achieved a notable evaluation score of 89% from ORCHA, a leading health app assessment organization. Launched internationally in Summer 2021, the company aims to support five million individuals by 2025 and is actively partnering with primary care practices in the UK, having established over 100 collaborations to date.

RareCan is an organization focused on enhancing research and improving outcomes for individuals with rare forms of cancer. It operates a direct-to-patient clinical trial platform that aims to expedite the processes involved in cancer research. By developing innovative patient and data pipelines, supported by proprietary technology, RareCan facilitates quicker and more cost-effective access for the pharmaceutical industry to the necessary patients and data. This initiative is designed to accelerate the development of precision medicine trials, thereby increasing the likelihood of successful outcomes in rare cancer treatments and ultimately contributing to the advancement of new therapies in the global cancer drug market.

Dyman Advanced Materials specializes in the development of a patented technology aimed at enhancing the manufacturing process of synthetic diamonds. This innovative approach seeks to improve the efficiency of the traditional high-pressure and high-temperature method used in diamond synthesis, resulting in reduced production costs. By providing a more economical production method, Dyman's technology serves both the industrial and gemstone market sectors, facilitating the broader availability of high-quality synthetic diamonds.